Abstract
Hazardous drinking is a major barrier to antiviral treatment eligibility among hepatitis C (HCV) patients. We evaluated differences
in substance-related coping, drinking-related consequences, and importance and confidence in ability to change alcohol use
among hazardous drinkers with and without HCV (N = 554; 93.5% male). We examined group differences between HCV+ patients (n = 43) and their negative HCV counterparts (n = 511).
Results indicate a higher percentage of HCV+ patients report using substances to cope with possible symptoms of PTSD (P < .05) and depression (P < .01), and endorse more lifetime drinking-related negative consequences than HCV patients (P < .01). Furthermore, HCV+ patients place greater importance on changing alcohol use (P < .01) but report less confidence in their ability to change (P < .01). Use of brief assessment and feedback with skills-based interventions to decrease alcohol use may be well-received
by HCV+ patients.
in substance-related coping, drinking-related consequences, and importance and confidence in ability to change alcohol use
among hazardous drinkers with and without HCV (N = 554; 93.5% male). We examined group differences between HCV+ patients (n = 43) and their negative HCV counterparts (n = 511).
Results indicate a higher percentage of HCV+ patients report using substances to cope with possible symptoms of PTSD (P < .05) and depression (P < .01), and endorse more lifetime drinking-related negative consequences than HCV patients (P < .01). Furthermore, HCV+ patients place greater importance on changing alcohol use (P < .01) but report less confidence in their ability to change (P < .01). Use of brief assessment and feedback with skills-based interventions to decrease alcohol use may be well-received
by HCV+ patients.
- Content Type Journal Article
- Pages 1-8
- DOI 10.1007/s10865-011-9394-9
- Authors
- Megan Oser, Department of Psychiatry, Brigham and Women’s Hospital, Harvard Medical School, 221 Longwood Avenue, 4th Floor, Boston, MA 02115, USA
- Michael Cucciare, Center for Health Care Evaluation, Veterans Affairs Palo Alto Health Care System and Stanford University School of Medicine, 795 Willow Road. (MPD-152), Menlo Park, CA 94025, USA
- John McKellar, Center for Health Care Evaluation, Veterans Affairs Palo Alto Health Care System and Stanford University School of Medicine, 795 Willow Road. (MPD-152), Menlo Park, CA 94025, USA
- Kenneth Weingardt, Center for Health Care Evaluation, Veterans Affairs Palo Alto Health Care System and Stanford University School of Medicine, 795 Willow Road. (MPD-152), Menlo Park, CA 94025, USA
- Journal Journal of Behavioral Medicine
- Online ISSN 1573-3521
- Print ISSN 0160-7715